Menu

Biodexa Pharmaceuticals Plc BDRX

Full chart Compare
Set alert

Price alert · BDRX

All alert types
2.48 USD +0.07 (+2.88%)

At closeNov 6, 2026, 6:48 PM EST

2.45 -0.03 -1.19%

After hours · Nov 6, 6:48 PM ET

2.28 Day range 2.70
2.41 52-week range 352.00
YTD
-97.27%
1 year
-98.83%

Revenue & Expenses

Other Income → Expenses: $570.00KOther Operating Income → Expenses: $14.00KExpenses → Selling, General & Admin: $4.34MExpenses → Research & Development: $4.07MExpenses → Interest Expense: $41.00KIncome Tax Benefit → Expenses: $406.00KGross Profit → Expenses: $381.00KRevenue → Gross Profit: $381.00KNet Loss → Expenses: $7.08MOther Income$570.00KOther Operating Income$14.00KIncome Tax Benefit$406.00KGross Profit$381.00KNet Loss$7.08MExpenses$8.45MSelling, General & Admin$4.34MResearch & Development$4.07MInterest Expense$41.00KRevenue$381.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

BDRX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-8.64M-9.20M-8.01M-8.93M-7.00M
-6.38M-5.73M-7.08M-7.66M-5.46M
-4.00-4,000.00-80,000.00-6,200,000.00-5,440,000.00
BDRX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
8.53M1.67M5.97M2.84M10.06M
18.18M14.78M10.54M5.53M12.91M
6.77M6.46M5.86M2.36M2.46M
61.00K727.00K464.00K624.00K766.00K
11.40M8.32M4.68M3.16M10.45M
BDRX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-6.30M-12.39M-7.67M-7.73M-7.17M
-583.00K-598.00K-265.00K-220.00K-278.00K
13.04M8.56M10.23M47.00K8.80M
16.00K-9.00K-22.00K-42.00K-278.00K
6.87M-4.30M3.13M-7.22M2.52M